BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9232026)

  • 1. Analysis of transgene integration sites in transgenic pigs by fluorescence in situ hybridization.
    Kuipers HW; Langford GA; White DJ
    Transgenic Res; 1997 Jul; 6(4):253-9. PubMed ID: 9232026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of pigs transgenic for human decay-accelerating factor.
    Cozzi E; Tucker AW; Langford GA; Pino-Chavez G; Wright L; O'Connell MJ; Young VJ; Lancaster R; McLaughlin M; Hunt K; Bordin MC; White DJ
    Transplantation; 1997 Nov; 64(10):1383-92. PubMed ID: 9392299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
    Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation.
    Lavitrano M; Bacci ML; Forni M; Lazzereschi D; Di Stefano C; Fioretti D; Giancotti P; Marfé G; Pucci L; Renzi L; Wang H; Stoppacciaro A; Stassi G; Sargiacomo M; Sinibaldi P; Turchi V; Giovannoni R; Della Casa G; Seren E; Rossi G
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14230-5. PubMed ID: 12393815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of baseline expression of human decay accelerating factor transgene on graft survival and acute humoral xenograft rejection.
    Sun H; Chen G; Liu W; Kubelik D; Yang H; White DJ; Zhong R; Garcia B
    Transplantation; 2005 Nov; 80(9):1331-9. PubMed ID: 16314803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
    Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
    Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of a pig line transgenic for human membrane cofactor protein.
    Zhou CY; McInnes E; Parsons N; Langford G; Lancaster R; Richards A; Pino-Chavez G; Dos Santos Cruz G; Copeman L; Carrington C; Thompson S
    Xenotransplantation; 2002 May; 9(3):183-90. PubMed ID: 11983016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on some welfare-related parameters of hDAF transgenic pigs when compared with their conventional close relatives.
    Martelli G; Sardi L; Stancampiano L; Govoni N; Zannoni A; Nannoni E; Forni M; Bacci ML
    Animal; 2014 May; 8(5):810-6. PubMed ID: 24739353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection.
    Rosengard AM; Cary NR; Langford GA; Tucker AW; Wallwork J; White DJ
    Transplantation; 1995 May; 59(9):1325-33. PubMed ID: 7539168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor.
    Pascher A; Poehlein C; Storck M; Prestel R; Mueller-Hoecker J; White DJ; Abendroth D; Hammer C
    Transplantation; 1997 Aug; 64(3):384-91. PubMed ID: 9275100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful cross-breeding of cloned pigs expressing endo-beta-galactosidase C and human decay accelerating factor.
    Yazaki S; Iwamoto M; Onishi A; Miwa Y; Suzuki S; Fuchimoto D; Sembon S; Furusawa T; Hashimoto M; Oishi T; Liu D; Nagasaka T; Kuzuya T; Maruyama S; Ogawa H; Kadomatsu K; Uchida K; Nakao A; Kobayashi T
    Xenotransplantation; 2009; 16(6):511-21. PubMed ID: 20042051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of human HLA transgenes in pigs by fluorescence in situ hybridization (FISH) for adjuvant study of human xenotransplantation.
    Wang BT; Tu CF; Hsieh LJ; Tai HC; Chiu YL; Lee JM; Kuo SJ; Tsuji K; Lee CJ
    Xenotransplantation; 2004 Sep; 11(5):471-5. PubMed ID: 15303984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood.
    Storck M; Abendroth D; Prestel R; Pino-Chavez G; Müller-Höker J; White DJ; Hammer C
    Transplantation; 1997 Jan; 63(2):304-10. PubMed ID: 9020335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
    Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
    Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between human decay-accelerating factor (hDAF) expression in pig cells and inhibition of human serum anti-pig cytotoxicity: value of highly expressed hDAF for xenotransplantation.
    Liu D; Kobayashi T; Onishi A; Furusawa T; Iwamoto M; Suzuki S; Miwa Y; Nagasaka T; Maruyama S; Kadomatsu K; Uchida K; Nakao A
    Xenotransplantation; 2007 Jan; 14(1):67-73. PubMed ID: 17214706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficiency of transgenesis using sperm-mediated gene transfer: generation of hDAF transgenic pigs.
    Lazzereschi D; Forni M; Cappello F; Bacci ML; Di Stefano C; Marfé G; Giancotti P; Renzi L; Wang HJ; Rossi M; Della Casa G; Pretagostini R; Frati G; Bruzzone P; Stassi G; Stoppacciaro A; Turchi V; Cortesini R; Sinibaldi P; Frati L; Lavitrano M
    Transplant Proc; 2000 Aug; 32(5):892-4. PubMed ID: 10936262
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors.
    Schuurman HJ; Pino-Chavez G; Phillips MJ; Thomas L; White DJ; Cozzi E
    Transplantation; 2002 Apr; 73(7):1146-51. PubMed ID: 11965048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates.
    Charreau B; Ménoret S; Tesson L; Azimzadeh A; Audet M; Wolf P; Marquet R; Verbakel C; Ijzermans J; Cowan P; Pearse M; d'Apice A; Soulillou JP; Anegon I
    Mol Med; 1999 Sep; 5(9):617-30. PubMed ID: 10551903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hDAF exogene protects swine endothelial and peripheral blood mononuclear cells from xenoreactive antibody mediated cytotoxicity in hDAF transgenic pigs.
    Lee JM; Tu CF; Tai HC; Chou NK; Yang TS; Weng CN; Lee YC; Lee CJ; Lee PH
    Transplant Proc; 2006 Sep; 38(7):2270-2. PubMed ID: 16980062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.